The FDA has approved Neffy, a nasal spray formulation of epinephrine, offering a needle-free option for treating life-threatening allergic reactions known as anaphylaxis. This new treatment provides a convenient and accessible alternative to traditional injectable epinephrine, potentially improving access to rapid treatment and reducing barriers for patients.